4. | REFERENCES
  1. D. Mozaffarian, E.J. Benjamin, A.S. Go, et al. Heart disease and stroke statistics–2015 update: a report from the American Heart Association. Circulation, 131 (2015), pp. e29-e322
  2. Gillinov AM, Cosgrove DM, Blackstone EH, et al. Durability of mitral valve repair for degenerative disease. J Thorac Cardiovasc Surg. 1998;116(5):734‐743.
  3. Mohty D, Orszulak TA, Schaff HV, Avierinos JF, Tajik JA, Enriquez‐Sarano M. Very long‐term survival and durability of mitral valve repair for mitral valve prolapse. Circulation. 2001;104(12 suppl 1):i1‐i7.
  4. Suri RM, Schaff HV, Dearani JA, et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg. 2006;82(3):819‐826.
  5. A. Carpentier, Cardiac valve surgery–the “French correction. J Thorac Cardiovasc Surg, 86 (1983), pp. 323-337
  6. Frater RW, Berghuis J, Brown AL Jr, Ellis FH Jr. The experimental and clinical use of autogenous pericardium for the replacement and extension of mitral and tricuspid value cusps and chordae. J Cardiovasc Surg (Torino) 1965;6:214–28.
  7. David TE. Replacement of chordae tendineae with expanded polytetrafluoroethylene sutures. J Card Surg1989;4:286-90
  8. Zussa C., Frater R.W.M., Polesel E., Galloni M., and Valfrè C.: Artificial mitral valve chordae: experimental and clinical experience. Ann Thorac Surg 1990; 50: pp. 367-373
  9. V. Falk, J. Seeburger, M. Czesla, et al.How does the use of polytetrafluoroethylene neochordae for posterior mitral valve prolapse (loop technique) compare with leaflet resection? A prospective randomized trial J Thorac Cardiovasc Surg, 136 (2008), p. 1205 [discussion: 1205-1206]
  10. T.E. David, J. Bos, H. Rakowski. Mitral valve repair by replacement of chordae tendineae with polytetrafluoroethylene sutures. J Thorac Cardiovasc Surg, 101 (1991), pp. 495-501
  11. Perier P, Hohenberger W, Lakew F, Diegeler A. Prolapse of the posterior leaflet: resect or respect. Ann Cardiothorac Surg. 2015;4(3):273‐277.
  12. Cetinkaya A, Bar S, Mitral valve repair for posterior leaflet prolapse: Long‐term comparison of loop implantation vs resection. J Card Surg. 2019;35(1):11-20.
  13. Javadikasgari H, Mihaljevic T, Suri RM, et al. Simple versus complex degenerative mitral valve disease. J Thorac Cardiovasc Surg. 2018;156(1):122‐129.e16. doi:10.1016/j.jtcvs.2018.02.102
  14. Flameng W, Herijgers P, Bogaerts K. Recurrence of mitral valve regurgitation after mitral valve repair in degenerative valve disease. Circulation. 2003;107(12):1609–1613. doi:10.1161/01.CIR.0000058703.26715.9D
  15. Castillo JG, Anyanwu AC, Fuster V, Adams DH. A near 100% repair rate for mitral valve prolapse is achievable in a reference center: implications for future guidelines. J Thorac Cardiovasc Surg. 2012;144(2):308–312. doi:10.1016/j.jtcvs.2011.12.054
  16. Dumont E, Gillinov AM, Blackstone EH, et al. Reoperation after mitral valve repair for degenerative disease. Ann Thorac Surg. 2007;84(2):444–450. doi:10.1016/j.athoracsur.2007.03.078
  17. Athanasiou T, Chow A, Rao C, Aziz O, Siannis F, Ali A et al. Preservation of the mitral valve apparatus: evidence synthesis and critical reappraisal of surgical techniques. Eur J Cardiothorac Surg 2008;33:391–401
  18. Ibrahim M, Rao C, Athanasiou T. Artificial chordae for degenerative mitral valve disease: critical analysis of current techniques. Interact Cardiovasc Thorac Surg. 2012;15(6):1019‐1032. doi:10.1093/icvts/ivs387
  19. Gillinov A.M., and Banbury M.K.: Pre-measured artificial chordae for mitral valve repair. Ann Thorac Surg 2007; 84: pp. 2127-2129